Spots Global Cancer Trial Database for Role of the Immune Environment in Response to Therapy in Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Role of the Immune Environment in Response to Therapy in Breast Cancer
Official Title: Role of the Immune Environment in Response to Therapy in Breast Cancer
Study ID: NCT05396612
Study Description
Brief Summary: This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact Details
Name: Jennifer Zhang, MD
Affiliation: Abramson Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
